Many of those people have found relief in CBD oil.
Does CBD Help with OCD?
Products sourced from marijuana contain a considerable amount of THC. They induce a euphoric state of mind accompanied by a boost of appetite, deep relaxation, and the heightening of senses. This set of effects is known as the signature marijuana high. In low to moderate doses, THC can reduce anxiety and stress; however, higher amounts of THC are associated with aggravated feelings of anxiety and paranoid thinking patterns.
Understanding OCD: Frequently Asked Questions (FAQ)
CBD is the new promising molecule for the treatment of OCD and its symptoms. CBD has been shown to influence several aspects of our mental health, including feelings of anxiety, fear, panic, and compulsion. Since anxiety is one of the core symptoms of OCD, you can use CBD oil to curb it effectively without the side effects of pharmacological treatment. CBD has an excellent safety profile and is well tolerated by humans.
Background: Preclinical data implicate the endocannabinoid system in the pathology underlying obsessive-compulsive disorder (OCD), while survey data have linked OCD symptoms to increased cannabis use. Cannabis products are increasingly marketed as treatments for anxiety and other OCD-related symptoms. Yet, few studies have tested the acute effects of cannabis on psychiatric symptoms in humans.
Results: Twelve participants completed the study. THC increased heart rate, blood pressure, and intoxication compared with CBD and placebo. Self-reported OCD symptoms and anxiety decreased over time in all three conditions. Although OCD symptoms did not vary as a function of cannabis varietal, state anxiety was significantly lower immediately after placebo administration relative to both THC and CBD.
Conclusions: This is the first placebo-controlled investigation of cannabis in adults with OCD. The data suggest that smoked cannabis, whether containing primarily THC or CBD, has little acute impact on OCD symptoms and yields smaller reductions in anxiety compared to placebo.
Clearly, research efforts have not been extensive enough to determine whether marijuana and CBD might be helpful or harmful for people with OCD. There’s still a lot of energy around this topic, though, and a few researchers plan to conduct larger-scale surveys of people with OCD—perhaps in preparation for research studies. (For more on these, stay tuned to the NOCD blog.)
A 2016 study sheds additional light on the possible neurobiology of these effects. When CB1 receptors—which are blocked indirectly by CBD—were deleted in specific neurons, mice were not able to shift from “goal-directed” to “habitual” behavior (possibly an analogue to compulsions in humans). Those researchers concluded that mice were switching between goal-directed and habitual behaviors based on activity in their CB1 receptors.
Subject to claims of effectiveness for all kinds of conditions, CBD is being marketed far more quickly than it can be researched. Due to its trendiness and a shaky but largely unenforced legal status, US sales grew from $108.1 million in 2014 to an estimated $813.2 million in 2019. By 2022 CBD sales are projected to approach $2 billion. Walgreens sells CBD products in nine states, CVS in eight. A staggering 14% of American adults say they use CBD, primarily for pain, anxiety, and insomnia.
Researchers have conducted a few animal studies with cannabinoids, yielding mixed results. Two studies, from 2010 and 2013, linked CBD with a reduction in compulsive-like marble-burying behavior among mice. However, as Dr. Feusner notes, the observed mouse behaviors like marble-burying or pathological grooming aren’t necessarily complete models for OCD in humans.
Cannabis products and OCD
On the other hand, countless people with or without psychiatric disorders say that marijuana and/or CBD help them feel better. Much research, though in its early form, supports the effectiveness of both medical marijuana and CBD for specific conditions. But, as stated in the National Academies report, there’s only limited evidence for a small number of conditions.
Although 2-3% of the population has OCD, it doesn’t get enough attention from researchers around the world. This is reflected in the fact that no new medication for OCD has been developed since 1997. Research gravitates toward conditions that are more prominent in our media, already receive better funding, and are at least a bit better understood—think depression and PTSD. There is always remarkable research emerging on OCD, but typically not on the same scale.
Meanwhile, a 2017 clinical trial at the New York State Psychiatric Institute called “Effects of Marijuana on Symptoms of OCD,” has yet to post results. If results do emerge, they’ll come from only 14 participants—a great start, but hardly conclusive. That marijuana remains illegal and stigmatized in so many places limits sample sizes and therefore study progress, and researchers must do what they can with a limited patient population.
Another substance to worry about?
People say all kinds of things about marijuana and CBD. They range from potentially true to probably nonsensical, and the longtime illegality of cannabinoid products has only made it harder to get any research done. Everyone is confused—especially those with mental health conditions, who might have the same desire to try these substances but a reduced ability to tolerate their effects.
Very little or no research has been conducted on most mental health conditions in relation to the effects of cannabis products. Confusion is the status quo with both substances, although the fact that CBD typically has milder effects and isn’t exactly illegal in most places has allowed manufacturers to shape public opinion significantly.